Rockville biotech continues buying spree with yet another acquisition

Rockville’s Emmes is sticking to its growth strategy for the past year with its fourth acquisition since a pandemic-era leadership change — and its first so far this year. The contract research organization, which conducts research and clinical trials for public and private sector customers, said Thursday it has purchased Plymouth, Massachusetts-based Casimir LLC, a fellow CRO focused on rare diseases, for an undisclosed amount. The 6-year-old Casimir brings to the table 31 U.S. employees and 25 clients, and experience in researching and testing more than 20 rare diseases.